{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:36:33Z","timestamp":1792704993369,"version":"4.5.0"},"reference-count":148,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/j.amjmed.2007.03.021","type":"journal-article","created":{"date-parts":[[2007,8,30]],"date-time":"2007-08-30T07:15:02Z","timestamp":1188458102000},"page":"791-798.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["The Safety of Oral Antifungal Treatments for Superficial Dermatophytosis and Onychomycosis: A Meta-analysis"],"prefix":"10.1016","volume":"120","author":[{"given":"Chia-Hsuin","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinong","family":"Young-Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Kurth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Orav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold K.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2007.03.021_bib1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0891-5520(02)00065-X","article-title":"Cutaneous infectious dermatophytosis, onychomycosis, and tinea versicolor","volume":"17","author":"Vander Straten","year":"2001","journal-title":"Infect Dis Clin N Am"},{"key":"10.1016\/j.amjmed.2007.03.021_bib2","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1001\/archderm.1997.03890450124022","article-title":"Prevalence of onychomycosis in patients attending a dermatology clinic in northeastern Ohio for other conditions","volume":"133","author":"Elewsk","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.amjmed.2007.03.021_bib3","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1067\/mjd.2000.107754","article-title":"A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns","volume":"43","author":"Ghannoum","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.amjmed.2007.03.021_bib4","first-page":"191","article-title":"Characteristics of office-based physician visits for cutaneous fungal infections: an analysis of 1990 to 1994 National Ambulatory Medical Care Survey Data","volume":"69","author":"Smith","year":"2002","journal-title":"Cutis"},{"key":"10.1016\/j.amjmed.2007.03.021_bib5","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0733-8635(03)00027-5","article-title":"The use of oral antifungal agents to treat onychomycosis","volume":"21","author":"Gupta","year":"2003","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.amjmed.2007.03.021_bib6","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/00000441-200305000-00008","article-title":"Terbinafine-associated hepatotoxicity","volume":"325","author":"Ajit","year":"2003","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.amjmed.2007.03.021_bib7","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1365-2125.1996.tb00049.x","article-title":"Postmarketing surveillance of oral terbinafine in the UK: report of a large cohort study","volume":"42","author":"O\u2019Sullivan","year":"1996","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.amjmed.2007.03.021_bib8","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1001\/archderm.1997.03890460029004","article-title":"Safety of oral terbinafine: results of a postmarketing surveillance study in 25,884 patients","volume":"133","author":"Hall","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.amjmed.2007.03.021_bib9","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1177\/120347540200600302","article-title":"Hepatic safety of itraconazole","author":"Gupta","year":"2002","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.amjmed.2007.03.021_bib10","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1046\/j.1365-2125.1999.00095.x","article-title":"A cohort study on the risk of acute liver injury among users of ketoconazole and other antifungal drugs","volume":"48","author":"Garcia-Rodriguez","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.amjmed.2007.03.021_bib11","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1346-8138.1996.tb04009.x","article-title":"Intermittent therapy with terbinafine for dermatophyte toe-onychomycosis: a new approach","volume":"23","author":"Alpsoy","year":"1996","journal-title":"J Dermatol"},{"key":"10.1016\/j.amjmed.2007.03.021_bib12","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/S0140-6736(99)04149-5","article-title":"Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement","volume":"354","author":"Moher","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2007.03.021_bib13","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1001\/archderm.134.12.1551","article-title":"How often does oral treatment of toenail onychomycosis produce a disease-free nail?","volume":"134","author":"Epstein","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.amjmed.2007.03.021_bib14","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/095466301317085336","article-title":"A systematic review of oral treatments for fungal infectious of the skin of the feet","volume":"12","author":"Bell-Syer","year":"2001","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.amjmed.2007.03.021_bib15","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1046\/j.1365-2133.2001.04378.x","article-title":"Long-term efficacy of antifungals in toenail onychomycosis: a critical review","volume":"145","author":"Cribier","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.amjmed.2007.03.021_bib16","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1046\/j.1365-2133.2002.04825.x","article-title":"Terbinafine in fungal infections of the nail: a meta-analysis of randomized clinical trials","volume":"147","author":"Haugh","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.amjmed.2007.03.021_bib17","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/archderm.138.6.811","article-title":"Oral treatments for toenail onychomycosis","volume":"138","author":"Crawford","year":"2002","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.amjmed.2007.03.021_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003584","article-title":"Oral treatments for fungal infections of the skin of the foot","author":"Bell-Syer","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.amjmed.2007.03.021_bib19","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s10227-002-0139-9","article-title":"Terbinafine is more effective than itraconazole in treating toenail onychomycosis: results from a meta-analysis of randomized controlled trials","author":"Krob","year":"2003","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.amjmed.2007.03.021_bib20","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1046\/j.1365-2133.2003.05728.x","article-title":"Cumulative meta-analysis of systematic antifungal agents for the treatment of onychomycosis","volume":"150","author":"Gupta","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.amjmed.2007.03.021_bib21","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1177\/009286159302700242","article-title":"An application of the beta-binomial model to combine and monitor medical event rates in clinical trials","volume":"27","author":"Chuang-Stein","year":"1993","journal-title":"Drug Inf J"},{"key":"10.1016\/j.amjmed.2007.03.021_bib22","series-title":"Biostatistics: A Foundation for Analysis in the Health Sciences","first-page":"97","article-title":"Probability distribution","author":"Daniel","year":"1999"},{"key":"10.1016\/j.amjmed.2007.03.021_bib23","first-page":"119","article-title":"Approximate is better than \u2018exact\u2019 for interval estimation of binomial proportions","volume":"52","author":"Agresti","year":"1998","journal-title":"Am Stat"},{"key":"10.1016\/j.amjmed.2007.03.021_bib24","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-5945-2-14","article-title":"Risk of serious skin disorders among users of oral antifungals: a population-based study","volume":"2","author":"Castellsague","year":"2002","journal-title":"BMC Dermatol"},{"key":"10.1016\/j.amjmed.2007.03.021_bib25","series-title":"Schiff\u2019s Diseases of the Liver","first-page":"1063","article-title":"Drug-induced liver disease","author":"Chitturi","year":"2003"},{"key":"10.1016\/j.amjmed.2007.03.021_bib26","doi-asserted-by":"crossref","first-page":"781","DOI":"10.7326\/0003-4819-141-10-200411160-00009","article-title":"Better reporting of harms in randomized trials: an extension of the CONSORT statement","volume":"141","author":"Ioannidis","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjmed.2007.03.021_fr1","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1439-0507.1995.tb00051.x","article-title":"Short therapy for tinea unguium with terbinafine: four different courses of treatment","volume":"38","author":"Albanese","year":"1995","journal-title":"Mycoses"},{"key":"10.1016\/j.amjmed.2007.03.021_fr2","doi-asserted-by":"crossref","first-page":"339","DOI":"10.7547\/87507315-89-7-339","article-title":"The safety of itraconazole in the diabetic population","volume":"89","author":"Albreski","year":"1999","journal-title":"J Am Podiatr Med Assoc"},{"key":"10.1016\/j.amjmed.2007.03.021_fr3","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1346-8138.1996.tb04009.x","article-title":"Intermittent therapy with terbinafine for dermatophyte toe-onychomycosis: a new approach","volume":"23","author":"Alpsoy","year":"1996","journal-title":"J Dermatol"},{"key":"10.1016\/j.amjmed.2007.03.021_fr4","first-page":"618","article-title":"Itraconazole pulse therapy in the treatment of disto-lateral subungual onychomycosis","volume":"13","author":"Aman","year":"2003","journal-title":"J Coll Physicians Surg Pak"},{"key":"10.1016\/j.amjmed.2007.03.021_fr5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/09546630252775171","article-title":"An open, randomized, comparative study of oral fluconazole, itraconazole and terbinafine therapy in onychomycosis","volume":"13","author":"Arca","year":"2002","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.amjmed.2007.03.021_fr6","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1365-4362.1995.tb03600.x","article-title":"Open randomized comparison of itraconazole versus terbinafine in onychomycosis","volume":"34","author":"Arenas","year":"1995","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.amjmed.2007.03.021_fr7","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1365-4362.1991.tb02648.x","article-title":"Onychomycosis treated with itraconazole or griseofulvin alone with and without a topical antimycotic or keratolytic agent","volume":"30","author":"Arenas","year":"1991","journal-title":"Int J Dermatol"},{"issue":"2 Pt 1","key":"10.1016\/j.amjmed.2007.03.021_fr8","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0190-9622(96)90327-8","article-title":"Intermittent fluconazole dosing in patients with onychomycosis: results of a pilot study","volume":"35","author":"Assaf","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.amjmed.2007.03.021_fr9","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/09546630500420183","article-title":"Combination of oral terbinafine and topical ciclopirox compared to oral terbinafine for the treatment of onychomycosis","volume":"16","author":"Avner","year":"2005","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.amjmed.2007.03.021_fr10","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1046\/j.1468-3083.2000.00049.x","article-title":"Continuous terbinafine or pulse itraconazole: a comparative study on onychomycosis","volume":"14","author":"Bahadir","year":"2000","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.amjmed.2007.03.021_fr11","first-page":"229","article-title":"Comparative double blind, double dummy study on the efficacy and safety of fluconazole 100 mg\/day versus terbinafine 250 mg\/day in the treatment of dermatomycoses","volume":"135","author":"Baldari","year":"2000","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1016\/j.amjmed.2007.03.021_fr12","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3109\/09546639709160278","article-title":"Comparative multicentre double-blind study of terbinafine (250 mg per day) versus griseofulvin (1 g per day) in the treatment of dermatophyte onychomycosis","volume":"8","author":"Baran","year":"1997","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.amjmed.2007.03.021_fr13","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1046\/j.1365-2133.2000.03545.x","article-title":"A randomized trial of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycoses affecting the matrix region","volume":"142","author":"Baran","year":"2000","journal-title":"Br J Dermatol"},{"issue":"Suppl 39","key":"10.1016\/j.amjmed.2007.03.021_fr14","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2133.1992.tb00009.x","article-title":"Treatment of onychomycosis with terbinafine","volume":"126","author":"Baudraz-Rosselet","year":"1992","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.amjmed.2007.03.021_fr15","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1046\/j.1365-4362.1997.00025.x","article-title":"Itraconazole in onychomycosis: intermittent dose schedule","volume":"36","author":"Bonifaz","year":"1997","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.amjmed.2007.03.021_fr16","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1439-0507.1998.tb00714.x","article-title":"Itraconazole in the treatment of tinea corporis and tinea cruris: comparison of two treatment schedules","volume":"41","author":"Boonk","year":"1998","journal-title":"Mycoses"},{"key":"10.1016\/j.amjmed.2007.03.021_fr17","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1365-4362.1989.tb02491.x","article-title":"Double-blind comparison of itraconazole with griseofulvin in the treatment of tinea corporis and tinea cruris","volume":"28","author":"Bourlond","year":"1989","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.amjmed.2007.03.021_fr18","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1136\/bmj.311.7010.919","article-title":"Randomised double blind comparison of terbinafine and itraconazole for treatment of toenail tinea infection","volume":"311","author":"Brautigam","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.amjmed.2007.03.021_fr19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1439-0507.1999.00404.x","article-title":"A comparison among four regimens of itraconazole treatment in onychomycosis","volume":"42","author":"Chen","year":"1999","journal-title":"Mycoses"},{"key":"10.1016\/j.amjmed.2007.03.021_fr20","doi-asserted-by":"crossref","first-page":"260","DOI":"10.7883\/yoken.JJID.2004.260","article-title":"Combination therapy of once-weekly fluconazole (100, 150, or 300 mg) with topical application of ketoconazole cream in the treatment of onychomycosis","volume":"57","author":"Chen","year":"2004","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.amjmed.2007.03.021_fr21","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1001\/archderm.1989.01670230079013","article-title":"A comparison of a new oral antifungal, terbinafine, with griseofulvin as therapy for tinea corporis","volume":"125","author":"Cole","year":"1989","journal-title":"Arch Dermatol"},{"issue":"5 Pt 3","key":"10.1016\/j.amjmed.2007.03.021_fr22","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/S0190-9622(98)70486-4","article-title":"Twelve weeks of continuous oral therapy for toenail onychomycosis caused by dermatophytes: a double-blind comparative trial of terbinafine 250 mg\/day versus itraconazole 200 mg\/day","volume":"38","author":"De Backer","year":"1998","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 2","key":"10.1016\/j.amjmed.2007.03.021_fr23","first-page":"21","article-title":"Comparison of oral fluconazole and topical clotrimazole in the treatment of fungal infections of the skin: European and American experience","volume":"31","author":"De Bersaques","year":"1992","journal-title":"Int J Dermatol"},{"issue":"Suppl 2","key":"10.1016\/j.amjmed.2007.03.021_fr24","first-page":"17","article-title":"Noncomparative study of fluconazole in the treatment of patients with common fungal infections of the skin","volume":"31","author":"De Cuyper","year":"1992","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.amjmed.2007.03.021_fr25","first-page":"180","article-title":"Pulse therapy with one-week itraconazole monthly for three or four months in the treatment of onychomycosis","volume":"56","author":"De Doncker","year":"1995","journal-title":"Cutis"},{"issue":"2 Pt 1","key":"10.1016\/j.amjmed.2007.03.021_fr26","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0190-9622(97)70275-5","article-title":"Itraconazole therapy is effective for pedal onychomycosis caused by some nondermatophyte molds and in mixed infection with dermatophytes and molds: a multicenter study with 36 patients","volume":"36","author":"De Doncker","year":"1997","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 43","key":"10.1016\/j.amjmed.2007.03.021_fr27","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1365-2133.1994.tb06089.x","article-title":"Two-week oral treatment of tinea pedis, comparing terbinafine (250 mg\/day) with itraconazole (100 mg\/day): a double-blind, multicentre study","volume":"130","author":"De Keyser","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.amjmed.2007.03.021_fr28","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/000155599750011020","article-title":"Randomized double-blind comparison of short-term itraconazole and terbinafine therapy for toenail onychomycosis","volume":"79","author":"Degreef","year":"1999","journal-title":"Acta Derm Venereol"},{"issue":"Suppl 1","key":"10.1016\/j.amjmed.2007.03.021_fr29","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1093\/clinids\/9.Supplement_1.S104","article-title":"Itraconazole in the treatment of dermatophytoses: a comparison of two daily dosages","volume":"9","author":"Degreef","year":"1987","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.amjmed.2007.03.021_fr30","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1990.tb02074.x","article-title":"A comparative double-blind study of terbinafine (Lamisil) and griseofulvin in tinea corporis and tinea cruris","volume":"15","author":"del Palacio Hernandez","year":"1990","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.amjmed.2007.03.021_fr31","first-page":"1","article-title":"Double-blind randomized comparative study on Tinea manuum and Tinea pedis treated with itraconazole and griseofulvin","volume":"84","author":"del Palacio","year":"1993","journal-title":"Actas Dermo-Sifiliogr"},{"key":"10.1016\/j.amjmed.2007.03.021_fr32","first-page":"148","article-title":"A double-blind comparison of itraconazole and fluconazole in tinea pedis and tinea manuum","volume":"4","author":"Difonzo","year":"1995","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.amjmed.2007.03.021_fr33","first-page":"73","article-title":"Treatment of onychomycosis with oral terbinafine: an open clinical trial","volume":"2","author":"Dobric","year":"1994","journal-title":"Acta Dermatovenerol Croat"},{"issue":"6 Pt 2","key":"10.1016\/j.amjmed.2007.03.021_fr34","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/S0190-9622(98)70491-8","article-title":"Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the fingernail","volume":"38","author":"Drake","year":"1998","journal-title":"J Am Acad Dermatol"},{"issue":"5 Pt 1","key":"10.1016\/j.amjmed.2007.03.021_fr35","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0190-9622(97)70111-7","article-title":"Oral terbinafine in the treatment of toenail onychomycosis: North American multicenter trial","volume":"37","author":"Drake","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.amjmed.2007.03.021_fr36","first-page":"217","article-title":"Double-blind, randomized comparison of itraconazole capsules vs. placebo in the treatment of toenail onychomycosis","volume":"59","author":"Elewski","year":"1997","journal-title":"Cutis"},{"key":"10.1016\/j.amjmed.2007.03.021_fr37","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1136\/bmj.318.7190.1031","article-title":"Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis","volume":"318","author":"Evans","year":"1999","journal-title":"BMJ"},{"issue":"5 Pt 1","key":"10.1016\/j.amjmed.2007.03.021_fr38","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/0190-9622(95)91454-4","article-title":"Double-blind, parallel-group comparison of terbinafine and griseofulvin in the treatment of toenail onychomycosis","volume":"32","author":"Faergemann","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.amjmed.2007.03.021_fr39","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1046\/j.1365-2133.1997.6181600.x","article-title":"A multicentre (double-blind) comparative study to assess the safety and efficacy of fluconazole and griseofulvin in the treatment of tinea corporis and tinea cruris","volume":"136","author":"Faergemann","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.amjmed.2007.03.021_fr40","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1046\/j.1365-2133.2002.04606.x","article-title":"Terbinafine (Lamisil) treatment of toenail onychomycosis in patients with insulin-dependent and non-insulin-dependent diabetes mellitus: a multicentre trial","volume":"146","author":"Farkas","year":"2002","journal-title":"Br J Dermatol"},{"issue":"Suppl 1","key":"10.1016\/j.amjmed.2007.03.021_fr41","first-page":"S15","article-title":"Italian multicentre trial comparing itraconazole with griseofulvin in the treatment of dermatomycoses","volume":"1","author":"Finzi","year":"1992","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"Suppl 2","key":"10.1016\/j.amjmed.2007.03.021_fr42","first-page":"12","article-title":"Comparative evaluation of oral fluconazole and oral ketoconazole in the treatment of fungal infections of the skin","volume":"31","author":"Fischbein","year":"1992","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.amjmed.2007.03.021_fr43","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0011-393X(97)80040-9","article-title":"An open-label, noncomparative, multicenter evaluation of fluconazole with or without urea nail pedicure for treatment of onychomycosis","volume":"58","author":"Fraki","year":"1997","journal-title":"Curr Ther Res Clin Exp"},{"key":"10.1016\/j.amjmed.2007.03.021_fr44","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1365-4362.1996.tb03645.x","article-title":"Onychomycosis treated with a short course of oral terbinafine","volume":"35","author":"Galimberti","year":"1996","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.amjmed.2007.03.021_fr45","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1439-0507.1998.tb00330.x","article-title":"An intermittent itraconazole 1-week dosing regimen for the treatment of toenail onychomycosis in dermatological practice","volume":"41","author":"Ginter","year":"1998","journal-title":"Mycoses"},{"key":"10.1016\/j.amjmed.2007.03.021_fr46","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/bmj.304.6835.1151","article-title":"Short term treatment of dermatophyte onychomycosis with terbinafine","volume":"304","author":"Goodfield","year":"1992","journal-title":"BMJ"},{"key":"10.1016\/j.amjmed.2007.03.021_fr47","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1365-2133.1989.tb08217.x","article-title":"Treatment of dermatophyte infection of the finger- and toe-nails with terbinafine (SF 86-327, Lamisil), an orally active fungicidal agent","volume":"121","author":"Goodfield","year":"1989","journal-title":"Br J Dermatol"},{"issue":"Suppl 2","key":"10.1016\/j.amjmed.2007.03.021_fr48","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/09546639009089036","article-title":"Clinical results with terbinafine in onychomycosis","volume":"1","author":"Goodfield","year":"1990","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.amjmed.2007.03.021_fr49","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/09546630050517207","article-title":"Combined treatment with surgery and short duration oral antifungal therapy in patients with limited dermatophyte toenail infection","volume":"11","author":"Goodfield","year":"2000","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.amjmed.2007.03.021_fr50","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000051643","article-title":"Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes","volume":"202","author":"Gupta","year":"2001","journal-title":"Dermatology"},{"key":"10.1016\/j.amjmed.2007.03.021_fr51","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1067\/mjd.2001.110874","article-title":"Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly","volume":"44","author":"Gupta","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.amjmed.2007.03.021_fr52","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1067\/mjd.2001.110644","article-title":"Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis","volume":"44","author":"Gupta","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.amjmed.2007.03.021_fr53","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/09546630050517658","article-title":"Itraconazole pulse therapy is effective in dermatophyte onychomycosis of the toenail: a double-blind placebo-controlled study","volume":"11","author":"Gupta","year":"2000","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.amjmed.2007.03.021_fr54","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1439-0507.1998.tb00716.x","article-title":"Safety and efficacy of intermittent therapy with itraconazole in finger- and toenail onychomycosis: a multicentre trial","volume":"41","author":"Haneke","year":"1998","journal-title":"Mycoses"},{"key":"10.1016\/j.amjmed.2007.03.021_fr55","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1159\/000017905","article-title":"Itraconazole in the treatment of onychomycosis: a double-blind comparison with miconazole","volume":"196","author":"Haneke","year":"1998","journal-title":"Dermatology"},{"key":"10.1016\/j.amjmed.2007.03.021_fr56","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0190-9622(95)90187-6","article-title":"Short-duration treatment of fingernail dermatophytosis: a randomized, double-blind study with terbinafine and griseofulvin","volume":"32","author":"Haneke","year":"1995","journal-title":"J Am Acad Dermatol"},{"issue":"5 Pt 1","key":"10.1016\/j.amjmed.2007.03.021_fr57","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0190-9622(88)70109-7","article-title":"Itraconazole therapy for recalcitrant dermatophyte infections","volume":"18","author":"Hanifin","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.amjmed.2007.03.021_fr58","first-page":"230","article-title":"A double-blind, randomized study comparing itraconazole pulse therapy with continuous dosing for the treatment of toe-nail onychomycosis","volume":"136","author":"Havu","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.amjmed.2007.03.021_fr59","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1365-2133.2000.03247.x","article-title":"A double-blind, randomized study to compare the efficacy and safety of terbinafine (Lamisil) with fluconazole (Diflucan) in the treatment of onychomycosis","volume":"142","author":"Havu","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.amjmed.2007.03.021_fr60","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1365-2133.1988.tb03229.x","article-title":"An evaluation of itraconazole in the management of onychomycosis","volume":"119","author":"Hay","year":"1988","journal-title":"Br J Dermatol"},{"issue":"3 II Suppl","key":"10.1016\/j.amjmed.2007.03.021_fr61","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/0190-9622(90)70255-G","article-title":"Itraconazole in the management of chronic dermatophytosis","volume":"23","author":"Hay","year":"1990","journal-title":"J Am Acad Dermatol"},{"issue":"2 Pt 1","key":"10.1016\/j.amjmed.2007.03.021_fr62","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0190-9622(91)70035-Z","article-title":"A comparative study of terbinafine versus griseofulvin in \u2018dry-type\u2019 dermatophyte infections","volume":"24","author":"Hay","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.amjmed.2007.03.021_fr63","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1365-2133.1995.tb08718.x","article-title":"A comparison of 2 weeks of terbinafine 250 mg\/day with 4 weeks of itraconazole 100 mg\/day in plantar-type tinea pedis","volume":"132","author":"Hay","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.amjmed.2007.03.021_fr64","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1001\/archderm.1995.01690200057011","article-title":"Treatment of toenail onychomycosis","volume":"131","author":"Hofmann","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.amjmed.2007.03.021_fr65","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1468-3083.1997.tb00505.x","article-title":"Itraconazole versus terbinafine (LAMISIL(registered trademark)): which is better for the treatment of onychomycosis?","volume":"9","author":"Honeyman","year":"1997","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.amjmed.2007.03.021_fr66","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1346-8138.2001.tb00106.x","article-title":"Long-term follow-up study of onychomycosis: cure rate and dropout rate with oral antifungal treatments","volume":"28","author":"Iozumi","year":"2001","journal-title":"J Dermatol"},{"key":"10.1016\/j.amjmed.2007.03.021_fr67","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1365-4362.1996.tb03667.x","article-title":"Double-blind, randomized comparison of itraconazole capsules and placebo in onychomycosis of toenail","volume":"35","author":"Jones","year":"1996","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.amjmed.2007.03.021_fr68","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1023\/A:1011028730323","article-title":"Onychomycosis in Tehran, Iran: prevailing fungi and treatment with itraconazole","volume":"150","author":"Khosravi","year":"2001","journal-title":"Mycopathologia"},{"key":"10.1016\/j.amjmed.2007.03.021_fr69","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/0011-393X(95)85113-5","article-title":"Efficacy and tolerability of itraconazole in patients with fingernail onychomycosis: a 6-week pilot study","volume":"56","author":"Kim","year":"1995","journal-title":"Curr Ther Res Clin Exp"},{"key":"10.1016\/j.amjmed.2007.03.021_fr70","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1128\/AAC.37.10.2064","article-title":"Treatment of tinea unguium with medium and high doses of ultramicrosize griseofulvin compared with that with itraconazole","volume":"37","author":"Korting","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.amjmed.2007.03.021_fr71","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3109\/09546639209088703","article-title":"Fluconazole in the treatment of onychomycosis caused by dermatophytes","volume":"3","author":"Kuokkanen","year":"1992","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.amjmed.2007.03.021_fr72","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0011-393X(02)80040-6","article-title":"An open-label, multicenter study of the combination of amorolfine nail lacquer and oral itraconazole compared with oral itraconazole alone in the treatment of severe toenail onychomycosis","volume":"63","author":"Lecha","year":"2002","journal-title":"Curr Ther Res Clin Exp"},{"issue":"6 Pt 2","key":"10.1016\/j.amjmed.2007.03.021_fr73","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1016\/S0190-9622(98)70492-X","article-title":"Once-weekly fluconazole (450 mg) for 4, 6, or 9 months of treatment for distal subungual onychomycosis of the toenail","volume":"38","author":"Ling","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.amjmed.2007.03.021_fr74","doi-asserted-by":"crossref","first-page":"262","DOI":"10.4103\/0378-6323.16619","article-title":"An open randomized comparative study of oral itraconazole pulse and terbinafine pulse in the treatment of onychomycosis","volume":"71","author":"Mishra","year":"2005","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"14 Suppl 1","key":"10.1016\/j.amjmed.2007.03.021_fr75","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1093\/clinids\/14.Supplement_1.S77","article-title":"Therapy with fluconazole for tinea corporis, tinea cruris, tinea pedis","author":"Montero-Gei","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjmed.2007.03.021_fr76","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1365-4362.1996.tb03666.x","article-title":"Fluconazole in the treatment of severe onychomycosis","volume":"35","author":"Montero-Gei","year":"1996","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.amjmed.2007.03.021_fr77","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1365-2133.1994.tb06088.x","article-title":"Terbinafine in onychomycosis with involvement by non-dermatophytic fungi","volume":"130","author":"Nolting","year":"1994","journal-title":"Br J Dermatol Suppl"},{"key":"10.1016\/j.amjmed.2007.03.021_fr78","first-page":"99","article-title":"Treatment of dermatophytosis with new systemic antifungal agent, itraconazole","volume":"75","author":"Noppakun","year":"1992","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.amjmed.2007.03.021_fr79","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1046\/j.1365-4362.1998.00541.x","article-title":"A comparison of the efficacy of oral fluconazole, 150 mg\/week versus 50 mg\/day, in the treatment of tinea corporis, tinea cruris, tinea pedis, cutaneous candidosis","volume":"37","author":"Nozickova","year":"1998","journal-title":"Int J Dermatol"},{"issue":"Suppl 1","key":"10.1016\/j.amjmed.2007.03.021_fr80","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1093\/clinids\/9.Supplement_1.S119","article-title":"Itraconazole in the treatment of tinea corporis: a pilot study","volume":"9","author":"Nuijten","year":"1987","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.amjmed.2007.03.021_fr81","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0190-9622(96)90519-8","article-title":"A double-blind, randomized comparison of itraconazole capsules and placebo in the treatment of onychomycosis of the toenail","volume":"35","author":"Odom","year":"1996","journal-title":"J Am Acad Dermatol"},{"issue":"2 Pt 1","key":"10.1016\/j.amjmed.2007.03.021_fr82","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0190-9622(97)70286-X","article-title":"A multicenter, placebo-controlled, double-blind study of intermittent therapy with itraconazole for the treatment of onychomycosis of the fingernail","volume":"36","author":"Odom","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.amjmed.2007.03.021_fr83","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1177\/030006059202000504","article-title":"A comparison of itraconazole and griseofulvin in the treatment of tinea corporis and tinea cruris: a double-blind study","volume":"20","author":"Panagiotidou","year":"1992","journal-title":"J Int Med Res"},{"issue":"Suppl 1","key":"10.1016\/j.amjmed.2007.03.021_fr84","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1093\/clinids\/9.Supplement_1.S109","article-title":"Treatment of dermatophytoses and pityriasis versicolor with itraconazole","volume":"9","author":"Panconesi","year":"1987","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.amjmed.2007.03.021_fr85","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1159\/000246883","article-title":"Clinical experience with short schedules of itraconazole in the treatment of tinea corporis and\/or tinea cruris","volume":"189","author":"Parent","year":"1994","journal-title":"Dermatology"},{"issue":"2 Pt 1","key":"10.1016\/j.amjmed.2007.03.021_fr86","first-page":"232","article-title":"Double-blind comparison of itraconazole and placebo in the treatment of tinea corporis and tinea cruris","volume":"31","author":"Pariser","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.amjmed.2007.03.021_fr87","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/09546630410018076","article-title":"Pulsed versus continuous terbinafine dosing in the treatment of dermatophyte onychomycosis","volume":"15","author":"Pavlotsky","year":"2004","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.amjmed.2007.03.021_fr88","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/jac\/29.2.195","article-title":"Efficacy and safety of itraconazole in the long-term treatment of onychomycosis","volume":"29","author":"Piepponen","year":"1992","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.amjmed.2007.03.021_fr89","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/09546639509080588","article-title":"Treatment of tinea with itraconazole: an open multicentre study","volume":"6","author":"Rakosi","year":"1995","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.amjmed.2007.03.021_fr90","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1468-3083.1998.tb00762.x","article-title":"Efficacy and safety of itraconazole pulse therapy: Brazilian multicentric study on toenail onychomycosis caused by dermatophytes","volume":"11","author":"Ramos-e-Silva","year":"1998","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.amjmed.2007.03.021_fr91","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.1365-2133.2003.05381.x","article-title":"A randomized trial of amorolfine 5% solution nail lacquer in association with itraconazole pulse therapy compared with itraconazole alone in the treatment of Candida fingernail onychomycosis","volume":"149","author":"Rigopoulos","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.amjmed.2007.03.021_fr92","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/09546639209092742","article-title":"Treatment of onychomycosis with itraconazole","volume":"2","author":"Rongioletti","year":"1992","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.amjmed.2007.03.021_fr93","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2230.1990.tb02041.x","article-title":"Itraconazole in the treatment of superficial mycoses\u2014a double-blind study vs. placebo","volume":"15","author":"Roseeuw","year":"1990","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.amjmed.2007.03.021_fr94","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/09546630410035329","article-title":"Combination therapy consisting of week pulses of oral terbinafine plus topical application of terbinafine cream in the treatment of onychomycosis","volume":"15","author":"Sanmano","year":"2004","journal-title":"J Dermatolog Treat"},{"issue":"Suppl 1","key":"10.1016\/j.amjmed.2007.03.021_fr95","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1093\/clinids\/9.Supplement_1.S100","article-title":"Itraconazole in the treatment of superficial mycoses: an open trial of 40 cases","volume":"9","author":"Saul","year":"1987","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.amjmed.2007.03.021_fr96","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1365-2230.1989.tb00906.x","article-title":"Successful treatment of chronic tinea pedis (moccasin type) with terbinafine (Lamisil)","volume":"14","author":"Savin","year":"1989","journal-title":"Clin Exp Dermatol"},{"issue":"4 Pt 2","key":"10.1016\/j.amjmed.2007.03.021_fr97","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/0190-9622(90)70293-Q","article-title":"Treatment of chronic moccasin-type tinea pedis with terbinafine: a double-blind, placebo-controlled trial","volume":"23","author":"Savin","year":"1990","journal-title":"J Am Acad Dermatol"},{"issue":"6 Pt 2","key":"10.1016\/j.amjmed.2007.03.021_fr98","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/S0190-9622(98)70490-6","article-title":"Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toenail","volume":"38","author":"Scher","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.amjmed.2007.03.021_fr99","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1439-0507.1998.tb00715.x","article-title":"Itraconazole in the treatment of tinea pedis and tinea manuum: comparison of two treatment schedules","volume":"41","author":"Schuller","year":"1998","journal-title":"Mycoses"},{"key":"10.1016\/j.amjmed.2007.03.021_fr100","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0190-9622(96)90120-6","article-title":"Treatment of Candida nail infection with terbinafine","volume":"35","author":"Segal","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.amjmed.2007.03.021_fr101","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1046\/j.1365-4362.2000.00087-2.x","article-title":"The safety of terbinafine in patients over the age of 60 years: a multicenter trial in onychomycosis of the feet","volume":"39","author":"Smith","year":"2000","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.amjmed.2007.03.021_fr102","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1097\/00007611-199512000-00006","article-title":"An evaluation of the safety and efficacy of fluconazole in the treatment of onychomycosis","volume":"88","author":"Smith","year":"1995","journal-title":"South Med J"},{"key":"10.1016\/j.amjmed.2007.03.021_fr103","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000017881","article-title":"Fluconazole in the treatment of tinea corporis and tinea cruris","volume":"196","author":"Stary","year":"1998","journal-title":"Dermatology"},{"key":"10.1016\/j.amjmed.2007.03.021_fr104","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1365-4362.1994.tb01521.x","article-title":"Fluconazole versus ketoconazole in the treatment of dermatophytoses and cutaneous candidiasis","volume":"33","author":"Stengel","year":"1994","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.amjmed.2007.03.021_fr105","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2340\/0001555555776669","article-title":"Oral terbinafine in toenail dermatophytosis","volume":"77","author":"Svejgaard","year":"1997","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.amjmed.2007.03.021_fr106","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1046\/j.1439-0507.2000.00551.x","article-title":"Intermittent pulse therapy with itraconazole for onychomycosis","volume":"43","author":"Tang","year":"2000","journal-title":"Mycoses"},{"key":"10.1016\/j.amjmed.2007.03.021_fr107","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1046\/j.1365-2133.1997.6661651.x","article-title":"Evaluation of 6 weeks treatment of terbinafine in tinea unguium in a double-blind trial comparing 6 and 12 weeks therapy","volume":"136","author":"Tausch","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.amjmed.2007.03.021_fr108","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1046\/j.1365-4362.1998.00402.x","article-title":"Short-term itraconazole versus terbinafine in the treatment of tinea pedis or manus","volume":"37","author":"Tausch","year":"1998","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.amjmed.2007.03.021_fr109","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0190-9622(96)80057-0","article-title":"Treatment of dermatophyte nail infections: an open randomized study comparing intermittent terbinafine therapy with continuous terbinafine treatment and intermittent itraconazole therapy","volume":"34","author":"Tosti","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.amjmed.2007.03.021_fr110","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1365-4362.1992.tb01382.x","article-title":"Terbinafine: efficacy and safety in the treatment of dermatophytosis","volume":"31","author":"Tuzun","year":"1992","journal-title":"Int J Dermatol"},{"issue":"Suppl 39","key":"10.1016\/j.amjmed.2007.03.021_fr111","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1365-2133.1992.tb00008.x","article-title":"A randomized treatment duration-finding study of terbinafine in onychomycosis","volume":"126","author":"van der Schroeff","year":"1992","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.amjmed.2007.03.021_fr112","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1439-0507.1988.tb04419.x","article-title":"Double-blind comparison of itraconazole with griseofulvin in the treatment of tinea pedis and tinea manuum","volume":"31","author":"van Hecke","year":"1988","journal-title":"Mycoses"},{"key":"10.1016\/j.amjmed.2007.03.021_fr113","first-page":"388","article-title":"Oral treatment of tinea corporis and tinea cruris with terbinafine and griseofulvin: a randomized double blind comparative study","volume":"76","author":"Voravutinon","year":"1993","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.amjmed.2007.03.021_fr114","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2340\/0001555570137140","article-title":"Itraconazole in onychomycosis","volume":"70","author":"Walsoe","year":"1990","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.amjmed.2007.03.021_fr115","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000018177","article-title":"Therapeutic efficacy and safety of one-week intermittent therapy with itraconazole for onychomycosis in a Chinese patient population","volume":"199","author":"Wang","year":"1999","journal-title":"Dermatology"},{"key":"10.1016\/j.amjmed.2007.03.021_fr116","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jaad.2005.04.055","article-title":"Pulse versus continuous terbinafine for onychomycosis: a randomized, double-blind, controlled trial","volume":"53","author":"Warshaw","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"5 Pt 1","key":"10.1016\/j.amjmed.2007.03.021_fr117","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0190-9622(95)91815-9","article-title":"Terbinafine in onychomycosis of the toenail: a novel treatment protocol","volume":"33","author":"Watson","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.amjmed.2007.03.021_fr118","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1365-2133.1991.tb14752.x","article-title":"Successful 2-week treatment with terbinafine (Lamisil) for moccasin tinea pedis and tinea manuum","volume":"125","author":"White","year":"1991","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.amjmed.2007.03.021_fr119","first-page":"126","article-title":"A double blind study of itraconazole vs griseofulvin in patients with tinea pedis and tinea manus","volume":"107","author":"Wishart","year":"1994","journal-title":"N Z Med J"},{"key":"10.1016\/j.amjmed.2007.03.021_fr120","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2133.1995.tb02644.x","article-title":"Very short duration therapy with oral terbinafine for fingernail onychomycosis","volume":"133","author":"Wong","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.amjmed.2007.03.021_fr121","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1439-0507.1997.tb00258.x","article-title":"Small-dose itraconazole pulse therapy in the treatment of onychomycosis","volume":"40","author":"Wu","year":"1997","journal-title":"Mycoses"},{"key":"10.1016\/j.amjmed.2007.03.021_fr122","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1365-2230.1989.tb00907.x","article-title":"The successful treatment of finger Trichophyton rubrum onychomycosis with oral terbinafine","volume":"14","author":"Zaias","year":"1989","journal-title":"Clin Exp Dermatol"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934307004500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934307004500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T08:46:20Z","timestamp":1757580380000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934307004500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":148,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S0002934307004500"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2007.03.021","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Safety of Oral Antifungal Treatments for Superficial Dermatophytosis and Onychomycosis: A Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2007.03.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}